Found: 5
Select item for more details and to access through your institution.
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4284, doi. 10.3390/cancers14174284
- By:
- Publication type:
- Article
Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2012, v. 84, n. 2, p. 108, doi. 10.1159/000342650
- By:
- Publication type:
- Article
Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 11, p. 12325, doi. 10.1002/cam4.5931
- By:
- Publication type:
- Article
First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8530, doi. 10.1002/cam4.4367
- By:
- Publication type:
- Article